Coya Therapeutics, Inc. Common Stock

COYANASDAQ • USD
ThemeBiotech - Drug Development›Neuroscience & CNS
4.87 USD
↗ 0.06 (1.14%)🟢LIVE (AS OF 03:22 PM EDT)
🟢Market: OPEN

Coya Therapeutics, Inc. Common Stock (COYA) is currently trading at $4.87. Technicals currently rate "Neutral" while our fundamental analysis reads "Neutral". Key drivers include a robust Altman Z-Score, a weak Piotroski F-Score of 2/9, negative Return on Equity and a bullish Golden Cross on the moving averages. COYA is fairly valued relative to its sector peers based on current multiples.

Technical & fundamental data as of Oct 2, 2026.

Open?$4.85
High?$5.15
Low?$4.78
Prev. Close?$4.81
Volume?82.9K
Avg. Volume?131.4K
VWAP?$4.87
Rel. Volume?0.63x
Bid / Ask
Bid?$4.85 × 100
Ask?$4.89 × 200
Spread?$0.04
Midpoint?$4.87
Valuation & Ratios
Market Cap?112.8M
Shares Out?23.5M
Float?17.5M
Float %?74.5%
P/E Ratio?N/A
P/B Ratio?2.61
EPS?-$0.92
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary new therapies to enhance the function of regulatory T cells (Tregs). The company's initial development programs are focused on neurodegenerative, chronic inflammatory, autoimmune, and metabolic diseases with high unmet medical needs.
Themes
Biotech - Drug Development›Neuroscience & CNSBiotech - Drug Development›Immunology & Autoimmune
Employees
8
Market Cap
112.8M
Industry
PHARMACEUTICAL PREPARATIONS
Website
www.coyatherapeutics.com
Listed
2022-12-29
Address
12645 MEMORIAL DR., SUITE F1 #305
HOUSTON, TX 77024
Phone: 650.739.3939
Technical OutlookNeutral
Strong SellNeutralStrong Buy
Long-Term (Tide)?– Neutral(0/3)
Medium-Term (Wave)?▲ Bullish(+1/3)
Short-Term (Ripple)?▼ Bearish(-2/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
12
Z-Score?
100
Momentum?
65
Short Sent.?
31
Piotroski F-Score?2/9Weak
Altman Z-Score?14.21Safe
Confidence?46%Low
Full Fundamental Analysis →
Short InterestVery High
Short % of Float?6.79%Elevated
Short Interest?1.2M
Days to Cover?10.2
Free Float17.5M
Avg Daily Volume116.0K
Settlement Date2026-09-15
Financial Health
Current Ratio?13.40Strong
Quick Ratio?13.40Strong
Cash Ratio?12.29Strong
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
67/100
P/E?
N/A▾
P/B?
Peers
100
S&P
62
2.61CHEAP▾
P/S?
Peers
100
S&P
3
14.07HIGH▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-3.0CHEAP▾
EV/Sales?
Peers
100
S&P
15
8.69HIGH▾
Returns & Efficiency
ROE?
S&P
3
-50.1%WEAK▾
ROA?
S&P
3
-45.8%WEAK▾
Cash Flow & Enterprise
FCF?$-15722176
Enterprise Value?$69.7M
Fundamentals ratios updated end of day
MarketsMoversWatchlist